Astrid M. Dalsgaard
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.
Journal: Frontiers in oncology
Published: August 07, 2025
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.
Journal: Molecular oncology
Published: May 20, 2022
Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome.
Journal: Cancer research communications
Published: October 23, 2021
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.
Journal: British journal of cancer
Published: January 24, 2017
The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma.
Journal: Cancer research
Published: March 11, 2016
Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
Journal: Molecular oncology
Published: June 24, 2014
FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.
Journal: BMC cancer
Published: January 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026